Home / Cardiovascular system / Disopyramide
ATC C01BA03 · Antiarrhythmics, Class Ia
Disopyramide shortage
As of 2 Nov 2026, Disopyramide has a reported shortage in 2 of the 15 countries we track (Canada, Japan), covering 2 products from 2 companies.
Countries2/15
Products2packs or presentations
Companies21 listed
Short since24 Jan 202521 months ago
Earliest returnnot givencompany estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapan1 product shortAustraliaNo reported shortage
Timeline
CanadaJapan
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Sawai 4887 · Tokyo
Compared with similar medicines
ATC group C01BA · Antiarrhythmics, Class IaAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | RYTHMODAN (84 capsules (blisters)) | CHEPLAPHARM ARZNEIMITTEL GMBH | 24 Jan 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| JP | ジソピラミド徐放錠150mg「SW」 limited | 沢井製薬 | 18 May 2026 | not given | Manufacturing problem |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.